What Дезогестрел treats: Main Uses and Benefits

The therapeutic application of Дезогестрел (Desogestrel) is applied in contexts involving certain distressing symptoms and conditions characterized by periods of heightened symptoms.

Дезогестрел is indicated for preventing pregnancy and is also sometimes used to help with heavy or irregular menstruation and endometriosis.

---

Дезогестрел Therapeutic Scope

Дезогестрел is commonly used to help with the core need for unwanted conception prevention by providing a reliable method of systemic contraception. It is generally used by women seeking continuous birth control, particularly in patient groups who require a progestin-only formulation, such as during the postpartum period.

The medication is also applied across domains where additional symptomatic support is needed to ease symptoms associated with menstrual cycle dysfunction. This includes managing severe cramping (dysmenorrhea), excessive blood loss (menorrhagia), and may offer supportive benefit for chronic gynecological issues like endometriosis-associated pelvic pain.

---

“This form of hormonal support assists with maintaining functional stability and supports patients during episodes of heightened discomfort**.”

In appropriate formulations, it may assist with managing pronounced hyperandrogenic symptoms like acne and hirsutism, contributing to easing the overall symptom load**.

Quick Fact: Relief for Symptom Burden
Primary Therapeutic Goal	Prevention of Pregnancy
Symptom Relief Domains	Menstrual pain, heavy bleeding, hormone-related acne
Patient Benefit Focus	Assists with maintaining functional stability and cycle predictability

Regulatory References

1. U.S. National Library of Medicine’s MedlinePlus Drug Information

Eligibility Scope

Category	Official Regulatory Statement
Populations for whom use is allowed	Women of reproductive age are the indicated population for use as a contraceptive. Use is generally acceptable for women who are breastfeeding [CDC/WHO guidelines].
Populations for whom use is contraindicated	Active venous thromboembolic disorder (e.g., Deep Vein Thrombosis or Pulmonary Embolism). Known or suspected sex-steroid sensitive malignancies (e.g., breast cancer). Severe hepatic disease or tumors where liver function has not returned to normal. Undiagnosed vaginal bleeding. Hypersensitivity to the active substance.
Age-related eligibility rules	Use is limited to post-menarcheal adolescents and adult women. The medicine is not indicated for use in postmenopausal women, as its purpose is contraception.
Pregnancy and lactation eligibility status	Pregnancy is a contraindication; intake must be stopped if pregnancy is confirmed. Lactation is acceptable, often preferred over combined oral contraceptives.

Eligibility Classifications

The eligibility profile is defined by Contraindications (absolute prohibition) for conditions like vascular disease and specific cancers, and Indications for women seeking fertility control. The use of Desogestrel is not established in patients with renal insufficiency as formal studies have not been conducted. Eligibility is confined to the population whose condition and reproductive status are aligned with the official label.

Interactions with Other Medicines and Products

Desogestrel, when used in combination with ethinyl estradiol, has significant interactions primarily involving drug metabolism and specific antiviral regimens. These interactions can lead to either reduced efficacy or an increased risk of adverse reactions.

1. Drugs That Reduce Efficacy (Metabolic Induction)

Concomitant use with drugs that are potent hepatic enzyme inducers—primarily those that affect the CYP3A4 system—can significantly decrease the plasma concentration of desogestrel's active metabolite, etonogestrel. This reduction may result in a loss of contraceptive protection, breakthrough bleeding, and menstrual irregularities. Examples of interacting medicines or classes include:

• Anticonvulsants/Antiepileptic Drugs (e.g., Phenytoin, Carbamazepine, Barbiturates)
• Antibiotics (e.g., Rifampin, Griseofulvin)

2. Interaction with Hepatitis C Virus (HCV) Therapy

The co-administration of desogestrel-containing combined hormonal contraceptives is contraindicated with certain HCV combination drug regimens, such as those containing ombitasvir, paritaprevir, and ritonavir (with or without dasabuvir). This restriction is due to the potential for significant increases in Alanine Aminotransferase (ALT) levels. Use with other specific HCV agents, like glecaprevir/pibrentasvir, is also generally not recommended. Contraceptives must be discontinued before starting these specific antiviral treatments.

Дезогестрел is a progestin prodrug that is rapidly metabolized in the liver to its active metabolite, etonogestrel (3-ketodesogestrel). Etonogestrel acts as a selective agonist primarily targeting the intracellular progesterone receptor (PR) in various reproductive tissues, including the pituitary gland, cervix, and endometrium.

The activated hormone-receptor complex translocates to the cell nucleus, where it functions as a transcription factor, binding to Progestin Response Elements (PREs) in the DNA promoter regions. This interaction modifies the transcription of specific target genes, leading to an alteration in messenger RNA (mRNA) synthesis and subsequent protein production.

In the pituitary gland, this genomic action results in the suppression of gonadotropin secretion, specifically inhibiting the surge of luteinizing hormone (LH), which prevents follicular rupture. At the cervix, the mechanism induces a substantial increase in cervical mucus viscosity and quantity, creating a barrier. In the endometrium, it causes accelerated secretory transformation, leading to endometrial thinning and reduced receptivity. These downstream molecular and cellular effects collectively modulate the hypothalamic-pituitary-ovarian axis and local tissue function.

Administration Schedules and Protocol

Дезогестрел is an active component in oral tablets and is designated for daily administration at approximately the same time each day to maintain consistent systemic concentrations. Tablets may be taken with or without food. The long-term usage pattern is determined by the specific formulation used.

Two distinct administration schedules are recognized:

• Continuous Regimen: Used for the Progestogen-Only Pill (POP), which typically contains 0.075 mg of desogestrel. This regimen requires continuous daily intake of active tablets without any tablet-free interval.
• Cyclic Regimen: Used for Combined Oral Contraceptives (COCs). This schedule involves 21 consecutive days of active tablet intake, followed by a 7-day period where either inactive (placebo) tablets are taken or a pill-free break is observed.

The dosage regimen for postpubertal adolescents is generally the same as that established for adults. Protocols are established for missed doses. For the 0.075 mg POP formulation, protection is maintained if a tablet is taken less than 12 hours late. If a dose is missed by more than 12 hours, a specific protocol, including the use of a barrier method for the following seven days, is required. Furthermore, an episode of vomiting or severe diarrhea occurring within three to four hours of ingestion is treated as a missed dose due to the risk of incomplete absorption.

Research Evidence / Overview of Studies for Дезогестрел (Desogestrel)

---

Evidence for Use in Preventing Pregnancy

Desogestrel was studied for its primary role in prevention of pregnancy through large-scale clinical trials known as Pivotal Phase 3 trials. These studies, along with subsequent Systematic Reviews, research examined how frequently pregnancies occurred, which is a key outcome measured using the Pearl Index calculation. Pivotal Phase 3 trials evaluated outcomes using the Pearl Index for measuring contraceptive efficacy and also monitored inhibition of ovulation and characteristics of cycle control as outcomes related to systemic or functional imbalance.

The findings describe patterns observed in the studies across thousands of exposure cycles, with specific patterns of continuation observed in the study populations. The evidence describes the outcomes measured for this medication's use in birth control.

Evidence for Cycle and Symptom Management

Desogestrel was studied for its application in conditions characterized by fluctuating or episodic manifestations of the menstrual cycle, such as heavy menstrual bleeding (menorrhagia) and menstrual pain (dysmenorrhea). Research examined outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level. For heavy menstrual bleeding, studies monitored outcomes such as the measured amount of blood lost and changes in cycle predictability. Findings describe patterns observed in the studies that are associated with changes in cycle patterns.

What Is Still Uncertain About Дезогестрел Research

Research highlights what is known — and what is still uncertain — about desogestrel. Evidence quality varies across studies, and there is a noted lack of comparative evidence from large, head-to-head randomized trials comparing this POP against other hormonal contraceptives. Long-term effects are not fully established for chronic, non-contraceptive indications, meaning that the research provides context but not individual predictions about outcomes after many years of use. This highlights the areas where the current understanding remains incomplete.

Key Studies & References

1. Drug Therapy for Endometriosis-Associated Pain (U.S. Pharmacist Review)
2. Problematic Bleeding with Hormonal Contraception (Faculty of Sexual and Reproductive Healthcare Clinical Guidance)

Common questions about Дезогестрел (FAQ)

---

Q: Does Дезогестрел cause weight gain, or is that a myth?

Official regulatory documentation based on clinical trials lists weight increased as a common side effect of Desogestrel. This means that weight gain was reported in 1 to 10 out of every 100 people using the medicine during these studies.

---

Q: Can I take Дезогестрел if I'm over 35?

For the progestin-only formulation, being over the age of 35 is not listed as a specific prohibition in official product information. However, for combined formulations that contain estrogen, the medicine is officially restricted for women over 35 who smoke, due to the recognized increased risk of serious cardiovascular events.

---

Q: How quickly does Дезогестрел start working after the first dose?

According to official administration instructions, if administration begins on day one of the menstrual cycle, contraceptive protection is immediate. If administration begins on days two through five, official guidelines generally describe the need for an additional barrier method of contraception during the first seven days of use.

---

Q: If I miss a pill, how much protection do I lose?

Official instructions for the Progestogen-Only Pill (POP) state that contraceptive effectiveness is maintained only if a tablet is taken less than 12 hours late. If the dose is missed by more than 12 hours, protection may be reduced, and the regulatory protocol describes the use of barrier methods for the following seven days.

---

Q: Are there any long-term health risks associated with taking Дезогестрел for many years?

Regulatory documents define serious safety concerns, which include the risks of Venous Thromboembolism (VTE) (blood clots in veins) and an increased risk of breast cancer associated with current hormonal contraceptive use. The current official product information focuses on these specific documented concerns and does not provide an exhaustive summary of all potential long-term risks beyond what has been studied and reported.

---

Q: Does Дезогестрел help with acne?

While official documentation lists acne as a common side effect for the progestin-only pill, combined formulations containing Desogestrel and estrogen are sometimes studied and used for the improvement of acne symptoms. The outcome may vary depending on whether a progestin-only or combined formulation is used, according to available documentation themes.

---

Q: What's the difference between Дезогестрел and other minipills?

Desogestrel is considered a third-generation progestogen. Official regulatory texts note that unlike many older Progestin-Only Pills (POPs) which rely mainly on thickening cervical mucus, the Desogestrel POP is distinct because it primarily works by consistently inhibiting ovulation, which is the main way combined pills prevent pregnancy.

---

Q: Can Дезогестрел change my mood or cause anxiety?

Official documentation lists mood altered and depressed mood as common side effects observed in clinical trials. While anxiety is not commonly listed, changes in mood are a recognized, documented side effect categorized as common.

---

Q: Does taking Дезогестрел make my periods stop completely?

Yes, regulatory documents indicate that changes to the menstrual cycle are common. In clinical trials, up to 20 % of women using the Desogestrel Progestin-Only Pill experienced their bleeding becoming less frequent or totally absent (amenorrhoea) after a few months of use.

---

Q: What happens if I take antibiotics while using Дезогестрел?

Some antibiotics, specifically the enzyme inducers rifampin and griseofulvin, are known in official documents to reduce the concentration of the active ingredient, potentially lowering contraceptive effectiveness. The regulatory warnings focus specifically on certain enzyme inducers. Other antibiotics are not typically highlighted in official product warnings regarding reduced efficacy.

---

Q: Are there any herbal supplements that interact with Дезогестрел?

Yes. Official documentation specifically warns that the herbal supplement St. John's wort (Hypericum perforatum) can interfere with the way the medicine is processed by the body. This interaction can lead to a loss of contraceptive effect, and co-administration is officially advised against.

---

Q: Does Дезогестрел have a risk of blood clots?

Yes. Official safety information lists the risk of Venous Thromboembolism (VTE) (blood clots) and Arterial Thromboembolism (ATE) as serious safety considerations. The progestin-only formulation carries a lower comparative risk than combined pills, but the potential risk remains a formally documented warning.

---

Q: What should I do if I vomit or have severe diarrhea after taking a pill?

If vomiting or severe diarrhea occurs within three to four hours of taking the tablet, official protocol advises that this should be treated like a missed dose. The official protocol outlines that a barrier method of contraception should be used for the following seven days until seven consecutive active pills have been taken correctly.

---

Q: Is Дезогестрел safe for women who are breastfeeding?

Official guidelines state that Progestin-Only Pills are generally considered acceptable for women who are breastfeeding and are one of the most commonly suggested hormonal options over combined pills in official medical eligibility criteria. This is because progestin-only use does not appear to negatively affect the quantity or quality of breast milk.

---

Q: Does smoking affect how well Дезогестрел works?

For the progestin-only formulation, smoking is not listed as a contraindication. However, the combined formulation (which contains estrogen) is strictly prohibited for women over 35 who smoke, due to a significantly increased risk of serious cardiovascular events.

---

Q: What is the success rate or effectiveness percentage of Дезогестрел?

The success rate is often measured using the Pearl Index in clinical studies. Official information indicates that when taken correctly (perfect use), the Desogestrel Progestin-Only Pill is described as being over 99 % effective at preventing pregnancy and is considered highly effective.

---

Q: Why is the progestin-only pill often suggested over the combined pill?

Progestin-Only Pills are generally suggested in official guidance for women who cannot use estrogen-containing contraceptives. This may include women with an increased risk of blood clots, women who are breastfeeding, or those with certain medical conditions like specific types of migraines or high blood pressure.

---

Q: Is it possible to become pregnant if I take all my Дезогестрел pills correctly?

Official information states that no contraceptive method is 100 % effective. Although the Desogestrel POP is highly effective when used correctly, failure rates are measured in clinical trials, meaning a very small possibility of pregnancy remains even with perfect use.

---

Q: What is the purpose of the placebo or inactive pills (if any) in the Дезогестрел packet?

The Desogestrel Progestin-Only Pill typically does not contain placebo pills, requiring continuous daily intake of active tablets. Placebo pills are only used in the Combined Oral Contraceptive formulations to help the user maintain the daily routine and signal the start of a withdrawal bleed period.

---

Q: How does Дезогестрел impact blood sugar levels?

The active metabolite has been associated with effects on insulin levels. Official guidelines highlight that women with diabetes are typically monitored when using hormonal contraceptives. However, progestin-only methods are generally considered to have a minimal or negligible impact on insulin resistance compared to combined pills.

---

Q: How does Дезогестрел influence the uterine lining?

According to the official mechanism of action, the active ingredient causes changes in the endometrium (uterine lining). This action leads to endometrial thinning, which reduces the receptivity of the lining, making it more difficult for a fertilized egg to successfully implant.

---

Q: Does Дезогестрел cause changes in breast tenderness or size?

Official documentation lists mastalgia (breast pain or tenderness) as a common side effect. Changes in breast size or discharge have also been reported in clinical monitoring.

---

Q: Are allergic reactions to Дезогестрел common?

Allergic reactions are officially considered rare. Rare side effects listed in regulatory documents include hypersensitivity reactions such as rash, urticaria (hives), and erythema nodosum.

---

Q: Can Дезогестрел be used for conditions other than contraception?

The primary official purpose is for contraception (prevention of pregnancy). However, the drug has also been studied for and sometimes used to manage symptoms related to the menstrual cycle, such as heavy menstrual bleeding and menstrual pain.

---

Q: Are there any changes to my libido when using Дезогестрел?

Yes. Official documentation lists libido decreased as a common side effect. This means a reduction in sex drive was observed in clinical trials in 1 to 10 out of every 100 users.

---

Q: How long does Дезогестрел stay in the system after I stop taking it?

Desogestrel is rapidly converted to its active form, etonogestrel. The active form has a mean half-life of approximately 30 hours. This indicates that it takes roughly 5 to 6 days for the substance to be fully eliminated from the body after stopping use.

---

Q: Is it true that you must take Дезогестрел at the exact same time every day?

Official guidance advises taking the tablet at approximately the same time each day to maintain effectiveness. However, the specific Desogestrel formulation is noted for having a flexible window, allowing it to be taken up to 12 hours late without compromising contraceptive protection.

---

Q: Is there a generic version of Дезогестрел available?

Yes. Desogestrel is the International Nonproprietary Name (INN) for the active compound, and it is widely available as a generic medication under various brand names in many countries.

Storage and Disposal Conditions for Дезогестрел

The storage and disposal of Дезогестрел (Desogestrel) tablets are defined by mandatory constraints to maintain product stability and protect the environment.

Requirement Type	Official Regulatory Statement
Temperature Range	Store the tablets at a temperature not exceeding 25 C or 30 C (Controlled Room Temperature).
Environmental Protection	Keep the medicine in the original packaging to protect from light and moisture.
Child Safety	The product must be stored out of the sight and reach of children.
Stability After Opening	Stability is limited; for some formulations, the product must be used within 1 month after the protective sachet is first opened.
Disposal Restriction	Do not dispose of via wastewater or household waste.
Waste Handling	Unused or expired medication must be disposed of according to local regulatory requirements (e.g., returned to a pharmacy) because the active metabolite poses an environmental risk to fish.